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in cattle (17). Calves infected with the LR mutant exhibit
diminished clinical symptoms and reduced virus shedding from
the eye or trigeminal ganglionic virus relative to calves infected
with wild-type (wt) or the LR rescued virus (16, 17). Conversely, the LR mutant had similar growth properties in productively infected bovine kidney cells and the nasal cavities of
calves during acute infection. The LR mutant virus does not
reactivate from latency following treatment with dexamethasone, whereas all calves latently infected with wt virus or the
LR rescued virus shed infectious virus following dexamethasone treatment. During the transition from acute infection to
latency (establishment of latency), higher levels of apoptosis
occur in trigeminal ganglionic neurons of calves infected with
the LR mutant than in those of calves infected with wt BHV-1
(24). These studies indicate that wt expression of LR gene
products is required for the latency-reactivation cycle in cattle.
The LR gene has two open reading frames (ORFs), ORF-1
and ORF-2, and two reading frames that lack an initiating
ATG (reading frame B [RF-B] and RF-C) (Fig. 1A). The LR
mutant that was prepared contains three stop codons adjacent
to the first in-frame ATG of ORF-2 (Fig. 1B), suggesting that
the LR mutant would not express a protein containing the
product of ORF-2. An antibody directed against a peptide
located near the amino terminus of the ORF-2 product (P2)
recognizes a protein migrating near 40 kDa in productively
infected cells or cells transiently transfected with the wt LR
gene (4, 15, 18, 30). Since the ORF-2 product is only 25 kDa,
we suggested that splicing and/or posttranslational modifications yielded a larger protein. Another peptide antibody directed against the N terminus of the ORF-1 product did not
specifically recognize a virus-specific protein in infected or
transfected cells (15). Alternative splicing of LR RNA yields a
family of transcripts, and one of these transcripts has the potential to be translated into a protein that contains the ORF-2
product fused to the ORF-1 product (6).
Bovine kidney cells (MDBK) infected with wt BHV-1, but
not the LR mutant, express a protein with an approximate
molecular mass of 40 kDa that was recognized by the P2

Bovine herpesvirus 1 (BHV-1) belongs to the subfamily
Alphaherpesvirinae and shares a number of biological properties with herpes simplex virus types 1 and 2 (HSV-1 and HSV2) (19). BHV-1 establishes lifelong latency in trigeminal ganglionic neurons of the peripheral nervous system after initial
replication in mucosal epithelium. Virus reactivation and spread
to other susceptible animals occur after natural or corticosteroid-induced stress (28, 32). Infection can lead to conjunctivitis, pneumonia, genital disorders, abortions, and an upper respiratory infection referred to as “shipping fever” (35), which
cost the U.S. cattle industry at least $500 million/year (1).
Binding and entry of Pasteurella haemolytica and Pasteurella
multocida into bovine cells is enhanced if the cells are infected
with BHV-1 (9), supporting other studies concluding that
BHV-1 infection can promote secondary bacterial infections
(3, 10–12). CD8⫹-T-cell recognition of infected cells is impaired by repressing expression of major histocompatibility
complex class I and the transporter associated with antigen
presentation (13, 14, 26). CD4⫹-T-cell function is impaired
during acute infection of calves because BHV-1 infects CD4⫹
T cells and induces apoptosis (36).
The latency-related (LR) RNA is the only abundant viral
transcript detected in latently infected neurons (22, 28, 29). A
fraction of LR RNA is polyadenylated and alternatively spliced
in trigeminal ganglia, suggesting that LR RNA can be translated into more than one protein (6, 15). LR gene products
inhibit S-phase entry, and an LR protein is associated with
cyclin-dependent kinase 2 (cdk2) or cdc2/cyclin complexes (15,
18). LR gene products also inhibit apoptosis (4), suggesting
that one important function of the LR gene is to promote
neuronal survival. A mutant BHV-1 strain that contains three
stop codons near the beginning of the LR RNA was constructed to test whether LR proteins play a role in virus growth
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The latency-related (LR) gene of bovine herpesvirus 1 (BHV-1) is abundantly expressed during latency. A
mutant BHV-1 strain that contains three stop codons at the 5ⴕ terminus of the LR gene (LR mutant) does not
reactivate from latency. This study demonstrates that the LR mutant does not express open reading frame 2
or an adjacent reading frame that lacks an initiating ATG (reading frame C). Since the LR mutant and
wild-type BHV-1 express similar levels of LR RNA, we conclude that LR protein expression plays an important
role in regulating the latency reactivation cycle in cattle.
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antibody (Fig. 1C). As previously reported (18), this protein
was expressed only at late times after infection. Although the
P2 peptide antibody has been useful for certain studies, the
40-kDa protein was difficult to detect in some experiments. We
have also observed considerable variability in titers of P2specific antibodies from rabbit to rabbit, suggesting that the P2

peptide is not a good immunogen. Consequently, we felt that it
was necessary to develop a better antibody against ORF-2.
To develop better antibodies directed against ORF-2, an LR
cDNA was cloned into a baculovirus expression vector that was
identified in trigeminal ganglia of calves infected for 7 days
(Fig. 2A). This cDNA contains most of the ORF-2 sequences,
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FIG. 1. Schematic of the BHV-1 LR gene and expression of an LR protein in infected cells. (A) Partial restriction map, location of LR RNA,
organization of ORFs, and the 3⬘ terminus of bICP0. The start sites for LR transcription during latency and productive infection were previously
described (2, 15). RF-B contains a reading frame after ORF-2 that lacks an initiating Met codon. RF-C also contains a reading frame that lacks
an initiating Met codon. The asterisk denotes the position of stop codons that are in frame with the respective ORF or reading frame. The
approximate sizes of the ORF and reading frames without an ATG are given. The position of the P2 peptide used to generate peptide-specific
antibodies was described previously (15). (B) DNA sequence of the SphI fragment and the mutation in the LR mutant. The first in-frame ATG
for ORF-2 is underlined. Stop codons in the mutant oligonucleotide are in all three reading frames (bold and underlined). The EcoRI restriction
enzyme site (GAATTC) was incorporated into the mutant oligonucleotide to facilitate screening for the recombinant virus. (C) MDBK cells were
infected with virus at a multiplicity of infection of 5, and at the designated times after infection (hours), whole-cell lysate was prepared. A peptide
antibody directed against the amino terminus of ORF-2 (P2 antibody, diluted 1:500) was used to probe the Western blot. The arrow indicates the
position of the LR-specific protein that migrates with an approximate molecular mass of 40 kDa. One hundred micrograms of protein was used
for each lane. (D) The samples (100 g) used for panel C were electrophoresed, the proteins were transferred to a membrane, and a Western blot
was performed with an antibody directed against ␤-actin (sc-1615; Santa Cruz Biotechnology, Santa Cruz, Calif.).
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and because of splicing, ORF-2 is fused to most of the coding
sequences comprising ORF-1 (6). RF-C is also fused to a portion of RF-B because of the unique splicing that occurred to
generate the 7-day cDNA. To express RF-C in baculovirus, the
7-day cDNA was released from pcDNA3.1(⫺) using EcoRI
and SalI and cloned into pBlueBacHis2, a baculovirus recombination plasmid (Invitrogen, Carlsbad, Calif.). To generate a
baculovirus that would express ORF-2 from the 7-day cDNA,
a SphI fragment derived from the 7-day cDNA was cloned into
pBlueBacHis2 such that ORF-2 was in frame with the His tag
(see the Fig. 2 legend for details of the cloning). Recombinant
baculoviruses were prepared by using Bac-N-Blue DNA (Invitrogen), and infectious baculovirus was propagated in insect
cells (SF9).
The ORF-2 and RF-C fusion proteins were partially purified
by nickel affinity chromatography, using a kit purchased from
Invitrogen. With respect to the ORF-2 fusion construct, a His
tag-specific antibody (Express) specifically recognized a protein migrating with an approximate molecular mass of 40 kDa
(Fig. 2B). The predicted molecular mass of the truncated
ORF-2 fusion protein that contains the His tag at its amino
terminus is approximately 40 kDa. The P2 antibody also specifically reacted with the ORF-2 fusion protein, as expected.
When the RF-C fusion protein was partially purified, the Express antibody specifically recognized a protein with an approximate molecular mass of 30 kDa (Fig. 2C). Splicing of the
7-day cDNA leads to the RF-C protein being fused to the
C-terminal sequences in the RF-B product (Fig. 2A), and with
the His tag at the N terminus, the RF-C fusion protein was
expected to migrate near 30 kDa. The P2 antibody did not
recognize the RF-C fusion protein that migrated near 30 kDa,
as expected. The two fusion proteins were further purified by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis,
and the fusion protein bands were excised, eluted, and then
injected into rabbits to generate polyclonal antibodies.
When crude cell lysate was prepared from MDBK cells
infected with wt BHV-1 for 24 or 48 h (Fig. 3A), the ORF-2
antibody consistently detected a protein migrating with an approximate molecular mass of 40 kDa. The 40-kDa protein was
not detected in MDBK cells infected with the LR mutant even
when the blot was overexposed as shown in Fig. 3A, but it was
detected when cells were infected with the LR rescued virus
(data not shown). In most experiments, the crude serum crossreacted with a cellular protein migrating around 35 kDa. A
polyclonal antibody directed against cdk-2 recognized similar
levels of cdk-2 in cells infected with the LR mutant and in
those with wt BHV-1 (Fig. 3B).
The antiserum directed against RF-C protein reacted with
several virus-specific proteins when MDBK cells were infected
with wt BHV-1 or the LR mutant and in mock-infected cells
(data not shown). This suggested that the RF-C serum crossreacted with other proteins or that the mutation at the beginning of ORF-2 did not block RF-C protein expression. To test
these possibilities, the immunoglobulin G (IgG) present in
RF-C antiserum was purified and used to perform immunoprecipitation-Western blot studies as described previously
(37). MDBK cells infected with wt BHV-1 (Fig. 3C) or the LR
rescued virus (data not shown) contained two proteins, one
migrating near 30 kDa and one near 40 to 42 kDa, that were
recognized by IgG in the RF-C antiserum at 24 h after infec-
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FIG. 2. Expression of LR ORFs in baculovirus expression vectors.
(A) An alternatively spliced LR transcript that was identified in trigeminal ganglia of infected calves at 7 days after infection (dpi) (6) was
cloned into pcDNA3.1⫺ (5). This cDNA is spliced at nucleotides 1180
and 1363 such that ORF-2 is fused with ORF-1. The numbers above
the ORF-2 schematic are nucleotide numbers of the LR gene, and the
numbers below ORF-2 are amino acid numbers. Splicing also generates a fusion protein containing a portion of the RF-C product fused
to the RF-B product. The LR cDNA begins at nucleotide 765 and ends
at nucleotide 2182. The details of cloning and characterizing the properties of this cDNA were described elsewhere (5). To construct a
baculovirus that expressed ORF-2, the SphI fragment containing
ORF-2 was cloned into the pGEM-11Zf(⫺) vector (Promega, Madison, Wis.) into the unique SphI site such that the SphI site at LR
nucleotide 810 was adjacent to the unique BamHI site in the vector.
This plasmid was digested with HindIII, treated with the Klenow fragment, and then digested with XhoI to release the LR fragment. This
LR fragment was cloned into pGEX(GST-5X) (Pharmacia Biotech,
Piscataway, N.J.) at unique SmaI and XhoI sites. The resulting fragment was digested to completion with XhoI and then partially digested
with BamHI. The resulting BamHI-XhoI fragment was then cloned
into pBlueBacHis2 at the unique BamHI-XhoI sites. This method
fused ORF-2 in frame with the His fusion sequences and allowed a
recombinant baculovirus that expressed the ORF-2 fusion protein to
be constructed. (B and C) Recombinant baculovirus strains were constructed and the viruses were grown in SF9 insect cells using procedures described by Invitrogen. Recombinants were characterized by
testing for LR protein expression using the Express antibody that
recognizes the His tag at the 5⬘ terminus of LR protein sequences
(R910-25; Invitrogen). Large-scale expression was carried out in 2-liter
flasks seeded with SF9 cells at a density of 2 ⫻ 106/ml in a total volume
of 1,000 ml. At 4 days after infection, cells were pelleted by centrifuging for 30 min at 8,000 rpm (Beckman J2-21 centrifuge, JA-10 rotor),
suspended in 20 ml of guanidinium lysis buffer (6 M guanidine hydrochloride, 20 mM sodium phosphate, 500 mM NaCl; pH 7.8). Suspended cells were then passed through an 18-gauge needle four times
to lyse the cells and shear cellular DNA. (B) His fusion protein purified
from SF9 cells infected with the ORF-2 fusion; (C) RF-C fusion
protein. The respective protein was loaded at 2 g/lane, Western blots
were performed, and the respective lanes were cut and incubated with
the designated antibodies. The P2 antibody was diluted 1:500 for these
studies. Western blot analysis was performed with the designated antibodies as previously described (18).
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tion. At 48 h after infection, the 30-kDa protein was readily
detected but the larger protein was not. In contrast, the same
IgG preparation did not detect these proteins in crude cell
lysate prepared from MDBK cells infected with the LR mutant, even when the Western blot was overexposed. For the
immunoprecipitation assays, similar levels of total protein were
used (Fig. 3D). In summary, these studies demonstrated that
the stop codons in the LR mutant prevented expression of
ORF-2 and RF-C.
Although LR RNA expression was detected in calves latently infected with the LR mutant by RT-PCR (16), we did
not analyze LR RNA expression in bovine cells following infection with the LR mutant or wt BHV-1. The results presented in Fig. 3 suggested that the LR gene encoded two
immunologically distinct proteins. However, it was also possible that the LR mutant did not express ORF-2 or the proteins

recognized by the RF-C product-specific antibody because the
LR mutant virus expressed low levels of LR RNA. To test
these possibilities, semiquantitative RT-PCR was performed
using primers that specifically amplify the LR RNA family of
transcripts, the BHV-1-encoded glycoprotein C mRNA, or
␤-actin mRNA (Fig. 4B). There was no dramatic difference in
the steady-state levels of LR RNA when MDBK cells were
infected with the LR mutant or wt BHV-1 (Fig. 4A). Similar
levels of gC RNA were also expressed in cells infected with the
LR mutant and those infected with wt BHV-1 (Fig. 4A). Since
the LR mutant and the wt virus express similar levels of bICP0
and release the same amount of infectious virus during productive infection (17), gC RNA expression was expected to be
the same. Finally, no dramatic differences were detected when
␤-actin levels were compared in cells infected with the LR
mutant and those infected with wt BHV-1. In summary, the
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FIG. 3. Western blot of MDBK cells infected with wt BHV-1 or the LR mutant. MDBK cells were infected with virus at a multiplicity of
infection of 4, and at the designated times after infection (hours), whole-cell lysate prepared. The polyclonal antibody directed against the ORF-2
fusion protein made from a baculovirus vector (A) or cdk2 (sc-748; Santa Cruz Biotechnology) (B) was used for Western blot analysis. All lanes
in panels A and B were loaded with 200 g of protein. The ORF-2 protein-specific antiserum was diluted 1:500 for Western blots, and the cdk2
antibody was diluted as described by the manufacturer. (C) Total cell lysate (2 mg protein) from mock-infected MDBK cells or cells infected with
the designated virus for 8, 24, or 48 h after was incubated with 5 g of IgG from normal rabbit serum for 1 h at 4°C. Immune complexes were
collected by using protein A beads. The supernatant was incubated with 3 g of IgG prepared from the RF-C protein-specific antiserum overnight
at 4°C, and immunocomplexes were collected by using protein A beads. The immunoprecipitates were washed as described previously (37). The
immunoprecipitates were electrophoresed on a sodium dodecyl sulfate–12% polyacrylamide gel, and Western blot analysis was performed with the
RF-C protein-specific IgG (1 l of a 0.7-mg/ml solution that was diluted 1:500). The details of the immunoprecipitation-Western blot assays were
described previously (37). (D) The samples (25 g of protein) described for panel C were electrophoresed and stained with Coomassie blue. The
arrows show the position of the LR-specific proteins detected in the cells infected with wt BHV-1 or the LR rescued virus (data not shown). The
results are representative of at least three experiments.
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levels of LR RNA, gC RNA, and ␤-actin were similar in
MDBK cells following infection with wt BHV-1 and with the
LR mutant.
The three stop codons within the LR mutant were designed
to inhibit synthesis of proteins encoded by ORF-2 but not
interfere with bICP0 expression and transcription of LR RNA.
Previous studies demonstrated that plasmids containing the
stop codons express similar levels of LR RNA but not the
40-kDa protein in transiently transfected cells (4) and that LR
RNA is expressed in calves latently infected with the LR mutant (16). It is clear that this mutation does not inhibit bICP0
protein expression and that the LR mutant has nearly identical
growth properties in cultured bovine cells (17). The results
obtained with the P2 antibody are consistent with the results
obtained with the ORF-2 protein-specific antiserum, strongly
suggesting that a protein containing a portion of the ORF-2
product is expressed.
To our surprise, two distinct proteins recognized by the
RF-C protein-specific IgG were expressed in productive infection, but the LR mutant did not express these proteins (Fig. 3).
The protein migrating at approximately 30 kDa is the predicted size of the RF-C product (Fig. 1A), suggesting that
unspliced LR transcripts produced RF-C protein. The larger
protein may be a posttranslationally modified form of the protein migrating near 30 kDa or the result of alternative splicing
of the LR RNA. Since the RF-C protein-specific antiserum
was made against a RF-C/RF-B fusion protein expressed from
baculovirus, it is possible that one of the proteins was derived
from RF-C and the other from RF-B. Although reading frames
without initiating ATGs can be expressed (8, 21), we cannot
rule out the possibility that a small splice occurs near the beginning of RF-C, which brings an adjacent ATG in frame with

RF-C. We are in the process of preparing antiserum that recognizes only RF-C, RF-B, and ORF-2 products to test these
possibilities.
Insertion of the LR gene into the HSV-1 latency-associated
transcript (LAT) locus restores high levels of spontaneous
reactivation in the rabbit eye model and in explant-induced
reactivation (27), suggesting that the LR gene and the LAT
contain common function(s) that promote the latency-reactivation cycle of HSV-1. When the LR gene is mutated and
recombined into the HSV-1 LAT locus, this virus behaves like
a LAT-minus mutant (25), suggesting that spontaneous reactivation was stimulated by expression of the BHV-1 LR ORF-2
and/or RF-C. LAT contains small ORFs, and there is a report
of a latency-associated antigen (7). Overexpression of LAT
ORF-2 stimulates productive infection in neuronal cells because it can substitute for ICP0 functions, suggesting that it has
functional significance during reactivation from latency (33,
34). An independent study concluded that ORFs within the
2-kb LAT are expressed in transient-transfection assays, but
LAT protein expression is not detected in infected cells (23).
Interestingly, Lock et al. (23) also concluded that LAT protein
expression is regulated at the level of translation. If one compares the ORFs in the LR gene with the LAT, there is no
striking similarity, suggesting that a regulatory RNA encoded
by the LAT promotes the high-reactivation phenotype in rabbits. The only known shared function of the LAT and the LR
gene is inhibiting apoptosis (20), suggesting that an antiapoptosis function plays an important role in the latency reactivation cycle of BHV-1 and HSV-1. In the context of the BHV-1
genome, it will be difficult to make mutations that block expression of RF-C without altering ORF-2 expression or inhibiting bICP0 expression, because the RF-C sequences are con-
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FIG. 4. RNA expression in infected MDBK cells (A) MDBK cells were infected with wt BHV-1 or the LR mutant at a multiplicity of infection
of 5. At the designated times after infection (hours), RNA was prepared from infected cells and cDNA synthesis was performed as previously
described (16). To detect LR RNA, first-strand cDNA synthesis was performed with the L3A downstream primer, which is antisense to LR RNA.
The L3A downstream primer spans nucleotides 1835 to 1815 (5⬘-GACGAGACCCCCGATTGCCG-3⬘) and was described previously (15).
Oligo(dT) priming was performed to detect gC and ␤-actin mRNA. ⫹, plasmids containing the LR or gC gene were included as positive controls.
Similar results were obtained with the LR rescued virus (data not shown). These results are representative of three studies. (B) DNA sequences
of primers used to amplify the cDNA used for panel A. The upstream LR gene primer was originally designated primer 1629, and the downstream
primer was primer 872 (15). The gC primers were described previously (31). All primers are listed as 5⬘-3⬘.
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tained in the coding sequences of bICP0 and ORF-2. However,
such studies are possible if these individual protein coding
domains are inserted into an HSV-1 LAT mutant and then
assayed in a rabbit or mouse model system.
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